LAPTM5 and metabolic dysfunction-associated steatohepatitis: Moreover, hepatocyte lipid deposition due to the knockout of LAPTM5 was significantly suppressed by the CDC42 knockdown, suggesting that LAPTM5 regulates the NASH progression by modulating the protein expression of CDC42 to mediate the activity of the MAPK signaling pathway.